Tuesday, September 15, 2026

North Korea Promotes ‘Manual Therapy’ as Traditional Cure for Wide Range of Illnesses

North Korea promotes manual therapy as a healing method, claiming it effectively treats various ailments without medication.

Luxury Vs. Famine: North Korea’s Elite Rush To Buy $100 Labubu Toys In The Land Of The Dead

North Korea's Future Reserve café mimics Starbucks, offering Labubu vouchers requiring 100 coffee purchases for redemption.

Is Russia Hiding Military Deals Behind a $40M Border Post With North Korea?

A new bridge over the Tumen River between North Korea and Russia is under construction, with plans for a significant immigration control center.

Tag: clinical trials

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

How International Collaboration is Revolutionizing Infectious Disease Research in Asia

Korea's Disease Control Agency establishes a framework for local medical institutions to join international clinical trials for infectious diseases.

GC Biopharma Unveils mRNA Vaccine Strategy at Seoul Pandemic X Summit 2026: What’s Next for COVID-19?

GC Biopharma presents its mRNA vaccine strategy at the Seoul Pandemic X Summit 2026, focusing on rapid responses to future pandemics.

Stem Cell Therapies Face Long Road to Market Despite Decades of Promise

Stem cell therapies show promise for treating diseases, but face significant commercialization challenges, including quality control and funding.

U.S. FDA to Streamline IND Process: What It Means for Asian Biotech Competitiveness in 2027

The U.S. aims to streamline drug approval processes to compete with China and Australia in attracting clinical trials, enhancing biotech growth.

AstraZeneca’s Elecoglipron: Can This New Weight Loss Pill Compete with GLP-1 Giants?

AstraZeneca's new weight-loss pill, elecoglipron, shows promising results in trials, competing with existing obesity treatments.

Cevidoplenib: The Game-Changing Autoimmune Drug Set for Global Launch in 2026

Oscotec's Cevidoplenib, an autoimmune drug, is set for global development with Agios, promising significant growth and revenue potential.

Sam Chun Dang Pharm Wins EMA Approval for Phase 1 Trial of Oral Insulin Candidate SCD0503

Samchundang Pharmaceutical's oral insulin candidate 'SCD0503' received final approval for Phase 1 clinical trials from EMA.

Celltrion Moves CT-G32 Into Final Preclinical Stage as Global Obesity Trial Preparation Accelerates

Celltrion advances CT-G32, a next-gen obesity treatment, targeting multiple pathways to enhance weight loss while preserving muscle mass.

Seoul St. Mary’s Prof. Jang Ki-yuk Selected as Sole Applied Medicine Researcher in National Leader Program

Prof. Jang Ki-yuk of Seoul St. Mary's Hospital receives $5.2M for cardiovascular disease research, focusing on plaque regression.

Metavia Highlights Strong Early Weight-Loss Data for DA-1726 at EASL 2026

MetaVia's obesity treatment candidate 'DA-1726' shows safety and weight loss effects in Phase 1 trials after 54 days.

HLB to Spotlight Liver and Bile Duct Cancer Pipeline at ASCO 2026 With Standalone Global Booth

HLB will showcase liver cancer drug candidates at ASCO 2026, including promising combination therapies and precision medicine studies.

Lunit to Present Five AI Biomarker Studies at ASCO 2026 Highlighting Expanded Clinical Applications

Lunit will present five AI studies at ASCO 2026, showcasing biomarker analysis for cancer treatment and patient response prediction.

Study Outlines Clinical Potential of Rejuvenating Retinal Cells to Treat Age-Related Vision Loss

Researchers reveal a breakthrough in treating eye diseases by rejuvenating aged cells, potentially restoring vision through epigenetic reprogramming.

KDDF Chief Calls for Structural Shift in Korea Biotech Beyond Technology Transfer

Dr. Park Young-min urges South Korea's biotech sector to shift from tech transfer to global collaboration for sustainable growth.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.